The effect of chronic DOAC treatment on clinical outcomes of hospitalized patients with COVID‐19

• Published in: International Journal of Clinical Practice Vol. 75; no. 9; pp. e14467 - n/a
• Main Authors: Aslan, Burhan, Akyüz, Abdurrahman, Işık, Ferhat, Çap, Murat, İnci, Ümit, Kaya, İlyas, Karahan, Mehmet Zülküf, Aktan, Adem, Bilge, Önder, Özbek, Mehmet, Altıntaş, Bernas, Boyraz, Bedrettin
• Format: Journal Article Web Resource
• Language: English
• Published: Hoboken John Wiley & Sons, Inc 01.09.2021; Hindawi Limited; John Wiley and Sons Inc
• Subjects: Cardiovascular diseases; Cell number; Clinical outcomes; COVID-19; Creatinine; Hospitalization; Infections; Intensive care; Lymphocytes; Mechanical ventilation; Mortality; Original Paper; Original Papers; Patients; Procalcitonin; Thrombosis

Background Recent findings indicate that thrombosis is one of the underlying pathophysiology and complication of COVID‐19 infection. Therefore, the prognosis of the disease may be more favourable in people who were under oral anticoagulant treatment before the COVID‐19 diagnosis. This study aims to...